FDA Taking Money From Big Pharma is once again exposed by James O’Keefe’s Excellence in Journalism undercover reporters at Project Veritas. So, here’s the deal in a nutshell. Big Pharma is sending money to the FDA to help ensure their products are approved in a timely fashion. FDA Executive Officer Chris Cole, says, the drug companies, the food companies, the vaccine companies. They pay us hundreds of millions of dollars per year to hire and keep the reviewers to approve their products! 😡
FDA Executive Officer Chris Cole Exposes Close Ties Between Agency and Pharmaceutical Companies: ‘Almost a Billion Dollars a Year Going into FDA’s Budget from the People we Regulate’. Video credit, Project Veritas.
Project Veritas published Part Two of its series on the FDA on Wednesday night which featured FDA Executive Officer, Christopher Cole, speaking about the inner workings of the agency including the FDA’s conflicts of interest, overspending, and why it’s hard for those within the agency to speak out on such abuses. In the above footage, Cole talks about the impact that pharmaceutical companies have on the agency including the process for approving drugs. It’s all about the Benjamins Baby!
A long time ago, Congress approved user fees for the FDA. Basically, we charge the industry millions of dollars in order to hire more drug reviewers and vaccine reviewers, which will speed up the approval process, so they make more money, Cole says in the footage. He then reveals that the FDA tones down the impact that these user fees have on the agency’s operations because, they’re dependent on the drug companies, the vaccine companies, and these other companies for their agency to operate.
FDA OFFICIAL STATEMENT: The person purportedly in the video does not work on vaccine matters and does not represent the views of the FDA nor does he speak on behalf of the agency. User fees provide instrumental funding for the FDA’s independent review of medical products that make a difference in the lives of all Americans, without compromising the agency’s commitment to scientific integrity, public health and regulatory standards, patient safety, and transparency.